However, this information may serve to enhance the knowledge-base and prompt additional studies on the small subset of human patients with BRAF mutation-positive TCC, or alternatively, can be translated into research on other tumor types in humans that are more commonly associated with BRAF mutations, such as malignant melanoma [63]. Here, BRAF is linked to melanoma.